Interleukin-2 Inhibitor in Rheumatoid Arthritis Synovial Fluid Does not Inhibit Mononuclear Cell Responses to Mitogens

References

• Burmester G, Kalden J, Peter H, Schedel I, Beck M, Wittenborg A. Immunological and functional characteristics of peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis. Scand J Immunol 1978; 7: 405–417
   PubMed Web of Science ®Google Scholar
• Corrigall V, Panayi G S, Laurent R. Lymphocyte studies in rheumatoid arthritis. III. A comparative study of the responses of peripheral blood and synovial fluid lymphocytes to phytomitogens. Scand J Rheumarol 1979; 8: 10–16
   PubMed Web of Science ®Google Scholar
• Ivanyi L, Lehner T, Burry H. The response of synovial fluid lymphocytes to T and B stimulants in vitro. Immunology 1973; 25: 905–908
   PubMed Web of Science ®Google Scholar
• Sheldon P J, Papamichail M, Holborow E J. Studies on synovial fluid lymphocytes in rheumatoid arthritis. Ann Rheum Dis 1974; 33: 509–514
   PubMed Web of Science ®Google Scholar
• Silver R M, Redelman D, Zvaifler N J. Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behaviour with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF. Clin Immunol Immunopathol 1983; 27: 15–27
   PubMedGoogle Scholar
• Stratton J, Peter J. The responses of peripheral blood and synovial fluid lymphocytes of patients with rheumatoid arthritis to in vitro stimulation with mitogens. Clin Immunol Immunopathol 1978; 10: 233–241
   PubMedGoogle Scholar
• Beck P, Burmester G R, Ledwoch A, Urban C, Kalden J R. Autologous and allogeneic MLC-reactivity in patients with rheumatoid arthritis. J Clin Lab Immunol 1981; 6: 27–33
   PubMedGoogle Scholar
• Pope R, McChesney L, Tala1 N, Fischbach M. Characterisation of the defective autologous mixed lymphocyte response in rheumatoid arthritis. Arthritis Rheum 1984; 27: 1234–1244
   PubMedGoogle Scholar
• Burmester G R, Jahn B, Gramatzki M, Zacher, Kalden J R. Activated T cells in vivo and in vitro: Divergence in expression of Tac and la antigens in the nonblastoid small T cells in inflammation and normal T cells activated in vitro. J Immunol 1984; 133: 1230–1234
   PubMed Web of Science ®Google Scholar
• Galili V, Rosenthal L, Galili N, Klein E. Activated T cells in the synovial fluid of arthritic patients: Characterisation and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol 1979; 122: 878–883
   PubMed Web of Science ®Google Scholar
• Galili V, Rosenthal L, Klein E. Activated T cells in the synovial fluid of arthritic patients. II. In vitro activation of the autologous blood lymphocytes. J Immunol 1981; 127: 430–432
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Kingsley G, Lanchbury J SS, Murphy J, Panayi G S. Expression of HLA-DR, DQ, and DP antigens and interleukin 2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: Evidence for “frustrated” activation. J Rheumatol 1987; 14: 662–666
   PubMed Web of Science ®Google Scholar
• Bertouch J V, Roberts-Thompson P J, Brooks P M, Bradley J. Lymphocyte subsets and inflammatory indices in synovial fluid and blood of patients with rheumatoid arthritis. J Rheumatol 1984; 11: 754–759
   PubMedGoogle Scholar
• Duclos M, Ziedler H, Liman W, Pichler W J, Rieber P, Peter H H. Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining. Rheumatol Int 1982; 2: 75–82
   PubMed Web of Science ®Google Scholar
• Fox R I, Fong S, Sabharwal N, Carstens S A, Kung P C, Vaughan J H. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 1982; 128: 351–354
   PubMed Web of Science ®Google Scholar
• Chattopadhyay C, Chattopadhyay H, Natvig J, Michaelson J, Mellbye O. Lack of suppressor cell activity in rheumatoid synovial fluid lymphocytes. Scand J Immunol 1979; 10: 309–316
   PubMed Web of Science ®Google Scholar
• Romain P, Burmester G, Enlow R, Winchester R. Multiple abnormalities in immunoregulatory function of synovial compartment T cells in patients with rheumatoid arthritis. Rheumatol Inr 1982; 2: 121–127
   PubMed Web of Science ®Google Scholar
• Miossec P, Kashiwado T, Ziff M. Inhibitor of interleukin 2 in rheumatoid synovial fluid. Arthritis Rheum 1987; 30: 121–129
   PubMed Web of Science ®Google Scholar
• Zembala M, Lemmel E M. Inhibitory factor(s) of lymphoproliferation produced by synovial fluid mononuclear cells from rheumatoid arthritis patients: The role of monocytes in suppression. J Immunol 1980; 125: 1087–1092
   PubMed Web of Science ®Google Scholar
• Kashiwado T, Miossec P, Oppenheimer-Marks N, Ziff M. Inhibitor of interleukin 2 synthesis and response in rheumatoid synovial fluid. Arthritis Rheum 1987; 30: 1339–1347
   PubMed Web of Science ®Google Scholar
• Symons J A, Wood N C, Di Giovine F S, Duff G W. Soluble interleukin 2 receptor in rheumatoid arthritis: correlation with disease activity, interleukin I and interleukin 2 inhibition. J Immunol 1988; 141: 2612–2618
   PubMed Web of Science ®Google Scholar
• Beyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Lab Invest 1968; 21: 77–80
   PubMed Web of Science ®Google Scholar
• Combe B, Pope R M, Fischbach M, Darnell B, Baron S, Talal N. Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985; 59: 520–528
   PubMed Web of Science ®Google Scholar
• Combe B, Andary M, Klein B, Clot J, Sany J. Regulation of interleukin 2 production in rheumatoid arthritis. J Rheumatol 1987; 14: 226–229
   PubMed Web of Science ®Google Scholar
• Miyaska N, Nakamura T, Russel I J, Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109–117
   PubMedGoogle Scholar
• Nouri A ME, Panayi G S. Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin 2 production in rheumatoid arthritis is not due to suppressor mechanisms. J Rheumatol 1987; 14: 902–906
   PubMed Web of Science ®Google Scholar
• McKenna R M, Ofosu-Appiah W, Warrington R J, Wilkins J A. lnterleukin 2 production and responsiveness in active and inactive rheumatoid arthritis. J Rheumarol 1986; 13: 28–32
   PubMed Web of Science ®Google Scholar
• Lemm G, Warnatz H. Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis. CIin Exp Immunol 1986; 64: 71–79
   PubMed Web of Science ®Google Scholar
• Moller G, Kashiwaga N. Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens. Immunology 1972; 22: 441–456
   PubMed Web of Science ®Google Scholar
• Klareskog L, Forsum V, Scheynuis A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Nail Acad Sci USA 1982; 79: 3632–3636
   PubMed Web of Science ®Google Scholar
• Musiani M, Zerbini M, Ferris S, Plavi M, Gentilomi G, La Placa M. Comparison of the immune response to epstein-barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1987; 46: 837–842
   PubMedGoogle Scholar
• Kinsella T D. Transformation of human lymphocytes in vitro by autologous and allogeneic rheumatoid synovial fluids. Ann Rheum Dis 1976; 35: 8–13
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Kingsley G, Haskard D, Panayi G. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988; 18: 1397–1404
   PubMed Web of Science ®Google Scholar
• Saunders M E, Makgoba M W, Shaw S. Human naive and memory T cells. Immunol Today 1988; 9: 195–199
   PubMedGoogle Scholar